Related references
Note: Only part of the references are listed.Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis
Ariane de Jesus Sousa-Batista et al.
AMERICAN JOURNAL OF THERAPEUTICS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology
Panagiota Papanagnou et al.
ONCOTARGETS AND THERAPY (2019)
Diagnosing lung cancer using etoposide microparticles labeled with 99mTc
Roberto Salvi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Effect of obesity on biodistribution of nanoparticles
Claudiana de Jesus Felismino et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging
Marta de Souza Albernaz et al.
PHARMACEUTICAL RESEARCH (2018)
Nanocarriers as phototherapeutic drug delivery system: Appraisal of three different nanosystems in an in vivo and in vitro exploratory study
Eduardo Ricci-Junior et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Cytotoxicity, genotoxicity, transplacental transfer and tissue disposition in pregnant rats mediated by nanoparticles: the case of magnetic core mesoporous silica nanoparticles
Suyene Rocha Pinto et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
In loco retention effect of magnetic core mesoporous silica nanoparticles doped with trastuzumab as intralesional nanodrug for breast cancer
Filipe Leal Portilho et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications
Lluis Pascual et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Microradiopharmaceutical for Metastatic Melanoma
Thiago Goulart Rosa et al.
PHARMACEUTICAL RESEARCH (2017)
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
Nazanin Hoshyar et al.
NANOMEDICINE (2016)
Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Jessica E. Maxwell et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancerassociated fibroblasts
Siham Moatassim-Billah et al.
ONCOTARGET (2016)
Alpha-, Delta- and PP-cells: Are They the Architectural Cornerstones of Islet Structure and Co-ordination?
Melissa F. Brereton et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)
Nanoparticle uptake: The phagocyte problem
Heather Herd Gustafson et al.
NANO TODAY (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Fatemeh Sadat Tabatabaei Mirakabad et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Development of Novel Nanoparticle for Bone Cancer
Beatriz Ferreira de Carvalho Patricio et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticals
Suyene Rocha Pinto et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Can Quality Control of Radiopharmaceuticals be Done Using Water and Ethanol?
Rodrigo dos Santos Almeida et al.
(2012)
Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances
Tetsuhide Ito et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Expert opinion: Responsive polymer nanoparticles in cancer therapy
William B. Liechty et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Sarbari Acharya et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Polymer-based nanocapsules for drug delivery
C. E. Mora-Huertas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Pancreatic neuroendocrine tumours
N. Alexakis et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Stabilisation of W/O/W double emulsion by polysaccharides as weak gels
M. Benna-Zayani et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2008)
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Marie Gaumet et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
David C. Metz et al.
GASTROENTEROLOGY (2008)
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
Michelle Longmire et al.
NANOMEDICINE (2008)
New frontiers in nanotechnology for cancer treatment
Frank Alexis et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy
Marco Volante et al.
MODERN PATHOLOGY (2007)
Endocrine tumours of the pancreas
K Öberg et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR
M Li et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
K Öberg et al.
ANNALS OF ONCOLOGY (2004)
Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration.
SR Schaffazick et al.
QUIMICA NOVA (2003)
Endocrine tumours of the pancreas: Review and recent advances
MH Mullan et al.
ANZ JOURNAL OF SURGERY (2001)
Share Paper
